Skip to content

Drug interactions

Insulin glargine + Insulin glargine-lixisenatide

Severity: Major

Insulin glargine and Insulin glargine-lixisenatide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The combination product already contains insulin glargine, so adding separate glargine duplicates the same basal insulin. This risks overdose and significant hypoglycemia.

What this interaction means in plain words

Insulin glargine and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Insulin glargine belongs to Endocrine; Insulin glargine-lixisenatide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Therapeutic duplication leading to additive insulin effect.

What to do

Avoid concurrent use; count glargine from the combination product toward the total basal dose. Use a single product and monitor glucose closely if transitioning.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine and Insulin glargine-lixisenatide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Insulin glargine with Insulin glargine-lixisenatide?

MediHelp rates the interaction as major. Insulin glargine and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. The combination product already contains insulin glargine, so adding separate glargine duplicates the same basal insulin. This risks overdose and significant hypoglycemia.

How serious is the interaction between Insulin glargine and Insulin glargine-lixisenatide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use; count glargine from the combination product toward the total basal dose. Use a single product and monitor glucose closely if transitioning.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in